Insmed Incorporated · NASDAQ:INSM
JPMorgan Chase & Co reported a 7.90% stake in Insmed Incorporated (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 30, 2025
JPMorgan Chase & Co reported a 7.90% stake in Insmed Incorporated, 15,164,893 shares, as a passive investor on Jun 30, 2025. Filed Jul 30, 2025 (Schedule 13G).
- Stake
- 7.90%
- Shares
- 15,164,893
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 7.90% | 15,164,893 |
Source
Related
- Insmed Incorporated
- JPMorgan Chase & Co
- Insmed Incorporated shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Jul 22, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Sep 4, 2025
- Form 4 · Hudson Paul · Oct 20, 2026
- Form 4 · Koppikar Utpal · Oct 20, 2026
- Form 4 · Brennan David R · Sep 11, 2026
- Form 4 · Sharoky Melvin Md · Aug 19, 2026
- Schedule 13G/A · Darwin Global Management, Ltd. · Aug 14, 2026